1ILQ image
Deposition Date 1998-12-17
Release Date 1998-12-23
Last Version Date 2024-10-23
Entry Detail
PDB ID:
1ILQ
Keywords:
Title:
CXCR-1 N-TERMINAL PEPTIDE BOUND TO INTERLEUKIN-8 (MINIMIZED MEAN)
Biological Source:
Source Organism:
Homo sapiens (Taxon ID: 9606)
Host Organism:
Method Details:
Experimental Method:
Conformers Calculated:
40
Conformers Submitted:
1
Selection Criteria:
LEAST RESTRAINT VIOLATION ENERGY
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:INTERLEUKIN-8 PRECURSOR
Gene (Uniprot):CXCL8
Chain IDs:A, B
Chain Length:72
Number of Molecules:2
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Molecule:INTERLEUKIN-8 RECEPTOR A
Gene (Uniprot):CXCR1
Mutations:YES
Chain IDs:C
Chain Length:19
Number of Molecules:1
Biological Source:Homo sapiens
Ligand Molecules
Primary Citation
Structure of a CXC chemokine-receptor fragment in complex with interleukin-8.
Structure Fold.Des. 7 157 168 (1999)
PMID: 10368283 DOI: 10.1016/S0969-2126(99)80022-7

Abstact

BACKGROUND: Interactions between CXC chemokines (e.g. interleukin-8, IL-8) and their receptors (e.g. CXCR-1) have a key role in host defense and disease by attracting and upregulating neutrophils to sites of inflammation. The transmembrane nature of the receptor impedes structure-based understanding of ligand interactions. Linear peptides based on the N-terminal, extracellular portion of the receptor CXCR-1 do bind to IL-8, however, and inhibit the binding of IL-8 to the full-length receptor. RESULTS: The NMR solution structure of the complex formed between IL-8 and one such receptor-based peptide indicates that a cleft between a loop and a beta hairpin constitute part of the receptor interaction surface on IL-8. Nine residues from the C terminus of the receptor peptide (corresponding to Pro21-Pro29 of CXCR-1) occupy the cleft in an extended fashion. Intermolecular contacts are mostly hydrophobic and sidechain mediated. CONCLUSIONS: The results offer the first details at an atomic level of the interaction between a chemokine and its receptor. Consideration of other biochemical data allow extrapolation to a model for the interaction of IL-8 with the full-length receptor. In this model, the heparin-binding residues of IL-8 are exposed, thereby allowing presentation of the chemokine from endothelial cell-surface glycosaminoglycans. This first glimpse of how IL-8 binds to its receptor provides a foundation for the structure-based design of chemokine antagonists.

Legend

Protein

Chemical

Disease

Primary Citation of related structures